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Abstract
Encapsulation remains a fundamental and consistent approach of fabrication of
drug and diagnostic delivery systems in the health space and natural polymers such
as polysaccharides and proteins continue to play significant roles. Micro- or
nanoencapsulation is employed for the conventional pharmaceuticals, biopharma-
ceuticals, or biologics, bioactives from natural sources and diagnostics such as bio-
markers. The outcome of any encapsulation depends on the technique employed
and the encapsulating material. The encapsulating materials employed influence the
physical and chemical attributes of the fabricated micro- and nanocapsules. The
encapsulating materials could be natural or synthetic, however, natural polymers
are preferred because they are human and environmentally friendly. Polysaccha-
rides and proteins are abundant in nature, biogenic, biocompatible, biodegradable
and possess biological functions making them materials of choice for encapsulation
of drugs and diagnostics. This chapter reviews the recent and advanced applications
of polysaccharides and proteins as nanocarrier materials for micro- and nanoencap-
sulation of therapeutics and diagnostics.
Keywords: natural polymers, biopolymers, drug delivery, nanoencapsulation,
microencapsulation, polysaccharides, proteins, therapeutic, diagnostic
1. Introduction
Encapsulation remains a fundamental and consistent approach of fabrication of
drug and diagnostic delivery systems in the health space and natural polymers such
as polysaccharides and proteins continue to play significant roles. Natural polymers
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(polysaccharides, proteins, and lipids), the macromolecules found in nature are
integral in the existence of living organisms especially polysaccharides and proteins.
Natural polymers constitute a huge portion of the earth’s organic matter because
they are synthesized by living organisms such as plants, animals, bacteria, and fungi
during their entire life cycle. Polysaccharides also referred to as glycans are the most
abundant organic compounds on earth. Polysaccharides are involved in many vital
functions in nature such as provision of support and stability for cells and tissues,
facilitation of cell communications, storage of energy, protection, lubrication, and
cell recognition. Proteins are regarded as the ‘workhorses’ of cells being involved in
many processes necessary for life including being the expressions of genetic
information.
Polysaccharides, proteins, and lipids interact in nature to enhance day to day
functions in living organisms. Polysaccharides bind with protein and lipids to form
glycoproteins and glycolipids respectively which can be used for cell communica-
tions. Other processes modulated by glycoconjugates (glycoproteins and glyco-
lipids) include molecular targeting, cell migration, cell–cell interactions, immune
responses, and blood clotting. Polysaccharides influence how proteins function and
how cells respond to stimuli. The behavior of a protein is affected by which glycan is
attached to it. Glycoproteins are abundant in the cells where they can serve as
regulatory switches.
Since natural polymers are biogenic, when used for therapeutic applications, the
body would usually identify with them and not treat as foreign bodies thereby
bypassing the body’s defense mechanisms leading to long circulation of the delivery
system and possible targeting to the site of action. The biological properties of
polysaccharides and proteins such as cell recognition and interactions, enzymatic
degradability, semblance to extracellular matrix and their chemical flexibility [1]
make them materials of choice for encapsulation of drugs and diagnostics. In addi-
tion, they are preferred to synthetic polymers because they are less toxic, eco-
friendly, biodegradable, biocompatible and renewable. Polysaccharides and pro-
teins are used for micro- and nanoencapsulation because they exhibit good process
efficiency, are modifiable and can be tailored to target the desired site of action,
have good rheological and emulsification/emulsion stabilizing properties, gelling
and film forming [2, 3]. In addition, use of polysaccharides and proteins align with
the interest and advocacy for ‘green’ production of drugs and diagnostics. This
chapter reviews the applications of polysaccharides and proteins as preferred
encapsulating materials in micro- and nanoencapsulation of therapeutics and
diagnostics.
2. Polysaccharide-based encapsulation
Carbohydrate monosaccharide molecules that are cohesively bound together by
glycosidic chains are termed polysaccharides [4]. The nature, sequence, and glyco-
sidic monosaccharide chains inherent in polysaccharides influence the molecular
and structural properties of polysaccharides. Water retention ability, digestibility,
gelation, and solubility properties of polysaccharides are dependent on the compo-
sition of their glycosidic monosaccharide chains [5–7]. Polysaccharides are usually
obtained through low cost production techniques with raw materials obtained from
natural sources. These polymers possess essential properties critical for drug deliv-
ery systems [8–11]. Polysaccharides are macromolecules structured in a linear or
branched pattern extensively used in both conventional and advanced drug delivery
systems as carriers, building blocks, bioactive materials and excipients. Due to their
flexibility, they can be derivatized and tailored to achieve certain functionalities
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that can enhance targeting and delivery properties. Some of the derivatives of
polysaccharides called semi-synthetic polysaccharides include carboxymethylcellu-
lose, starch acetate, methylcellulose, ethylpullulan, and chitosan sulfate. Polysac-
charides and their derivatives enhance delivery and diagnostic properties such as
mechanical strength, stability, protection, solubility, targeting, stimuli responsive-
ness, controlled release, self-regulation, adhesion, bioimaging, labeling, site-
specificity and multifuntionality which equip them to respond to stimuli, diagnose,
image, target and treat as single devices [12]. These potentials of polysaccharides
make them convenient materials for encapsulation conferring on the encapsulated
product the various benefits of encapsulation.
2.1 Polysaccharides in micro- and nanoencapsulation
Drug delivery systems make use of a wide range of polysaccharide-based deliv-
ery systems from plant (khaya gum, starch and cellulose) [13, 14], animal
(chitosan) [15], algae (alginate and carrageenan) and microbial (dextran and
xanthan gum) sources [16, 17] and cyclodextrins [18]. These polysaccharides deliv-
ery systems can interact with bioactive compounds ensuring that they act as innate
drug carriers which bind and encapsulate hydrophilic and hydrophobic functional
compounds [19]. The size, shape, and internal structure of these polysaccharide
delivery systems differ depending on several factors including the method of for-
mulation and the polysaccharide used in formulation [9]. Size is an integral com-
ponent of drug delivery systems since it affects their physicochemical stability,
encapsulation and release characteristics, and biological activity [9]. Encapsulation
of bioactive drug compounds can be achieved via a single or a combination of
polysaccharides.
Polysaccharides used for micro- or nanoencapsulation include varied types of
polysaccharides and utilization of specific polysaccharides for encapsulation is
dependent on its chemical non reactivity with active pharmaceutical ingredient,
chemical compatibility as well as stability target-selected delivery [20]. Micro and
nanoencapsulation are achieved majorly via chemical (emulsification, polymeriza-
tion, and liposomes) or physical (freeze-drying/lyophilization, spray drying,
co-crystallization, fluidized-bed coating encapsulation processes). Drugs with low
solubility and high permeability i.e. BCS class 2 drugs are usually formulated via
encapsulation to optimize bioavailability, stability, and controlled release of
drugs [20].
2.2 Merits and demerits in therapeutic delivery
Despite the many advances of encapsulation process, relatively few of these
products have been made commercially available due to many reasons which
include degradation of highly temperature sensitive compounds, difficulty in con-
trolling the particle size especially as the size of the yield is usually small [21]. Long
processing times, expensive costs of production and storage of these dosage forms
are also of concern. Table 1 shows varying polysaccharides utilized on the
encapsulation process stating the merits and demerits of each application.
2.3 Case studies/applications
2.3.1 Encapsulation of small molecules
Mankala et al., [19] incorporated aceclofenac, a nonsteroidal anti-inflammatory
drug (NSAID) with biological half-life of 4.3 h and a BCS class 2 drug into
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API Significance of the study Demerits of the encapsulation process/study set back Reference
1. Chitosan Microencapsulation Isoniazid and
rifabutin
Spray-dried chitosan microparticles inhibited bacterial
growth by 96%, demonstrating that microencapsulation
preserved drug antibacterial activity in vitro. Overall, the
obtained data suggest the potential of chitosan
microparticles for inhalable lung tuberculosis therapy.
Microparticles were sensitive to high temperatures and
the yield was extremely small. Control of the particle
size during the production process was difficult.
[22]
Nanoencapsulation Tamoxifen Compared to tamoxifen citrate suspension, the amount
of the drug permeated using the nano formulation was
increased from 1.5 to 90 times, in absence or in presence
of pancreatin or lipase. The encapsulation of tamoxifen
in lecithin/chitosan nanoparticles improved the non-
metabolized drug passing through the rat intestinal
tissue via paracellular transport.
The effect of enzymes on intestinal permeation of
tamoxifen was shown only when tamoxifen-loaded
nanoparticles were in intimate contact with the mucosal
surface.
The nanoparticle yield was extremely small.
[23]
Nanoencapsulation Gallic acid Gallic acid (GA) loaded chitosan nanoparticles (GANP)
treated mice, reversed the scopolamine induced amnesia
in mice which may be attributed to its antioxidant
properties and improved cholinergic functions. These
effects were significantly increased by the
administration of GANP compared with pure GA
administration, but no significant change was observed
for GANP.
The nanoparticles required coating with Tween 80 to
enhance the stability of the product. The yield of the
nanoparticles was extremely small.
[24, 25]
2. Alginate Microencapsulation Gallic acid Electro-spraying microencapsulation of Gallic acid
calcium alginate for use in management of dementia
provided alginate beads with a size of 200 μm - 1.3 mm.
Loading capacity acid varied from 7 to 12 g/100 g. There
was a faster release profile in simulated intestinal fluid
than in gastric fluid.
Difficulty in controlling particle size, moderate yields
for small batches was experienced. The need for special
handling and storage conditions was required.
[26, 27]
Nanoencapsulation IgY Controlled delivery of therapeutic agents by alginate
nanoparticles became an attractive issue in the gastric
organ. Some therapeutic agents such as proteins could
not tolerate severe conditions in the gastrointestinal
tract. Concentrations of a specific IgY as a prophylactic
The yield was small, and the formulation was not stable
at high temperatures. Degradation of highly
temperature- sensitive compounds was also experienced

































API Significance of the study Demerits of the encapsulation process/study set back Reference
agent against E. coli O157: H7 was entrapped in 0.2% w/v
sodium alginate nanoparticles by ionic gelation method.
Alg NPs prepared from 0.2%w/v stock solution could be
appropriate candidates for efficient and safe delivery of
IgY through the gastrointestinal tract.
Microencapsulation Paclitaxel Alginate microparticles were fabricated by an
emulsification technique and characterized. The in vitro
cytotoxicity activity of paclitaxel loaded microparticles
was assessed using human non-small cell lung cancer cell
lines (A549 and Calu-6). Results showed that exposure
of cells to pure paclitaxel and paclitaxel loaded
microparticles effectively inhibited the growth of A549
and Calu-6 cells similarly in a concentration- and time-
dependent manner thus its use in management of
primary or metastatic lung cancer.
The yield was small, and the formulation was not stable
at high temperatures. Clearance of the microparticles by
macrophages is expected to be high. This will alter its
overall bioavailability.
[29]
3. Hyaluronate Nanoencapsulation Recombinant
neuroglobin
The formulation of sodium hyaluronate nanoparticles
loaded with neuroglobin, showed that the formulation is
highly compatible for pharmaceutical use and may act as
a delivery system to transport neuroglobin within the
blood. After a stroke, the sodium hyaluronate
nanoparticles loaded with neuroglobin injected
intravenously at the onset of the reperfusion period, can
cross the BBB. They quickly reached the damaged nerve
cells, being detected inside cytoplasm. This delivery
system successfully carried the neuroprotective oxygen-
sensing protein NGB to the damaged ischemic brain
after 2 hr. and was retained after 24 hr. of reperfusion.
The nano particles must be preserved at low
temperatures.
[30]
Microencapsulation — Sodium hyaluronate was evaluated as a material for
inhalation due to its therapeutic potential, utility as a
formulation excipient or drug carrier, and ability to
target lung inflammation and cancer.
The microparticles was fabricated over long processing
























































API Significance of the study Demerits of the encapsulation process/study set back Reference
4. Cellulose
derivatives
Nanoencapsulation — Tempo-oxidized bacterial cellulose (TOBC) and sodium
alginate (SA) composites were prepared to improve the
properties of hydrogel for cell encapsulation. The
compression strength and chemical stability of the
TOBC/SA composites were increased compared with the
SA hydrogel, which indicated that TOBC performed an
important function in enhancing the structural,
mechanical and chemical stability of the composites.
Nanocellulose-alginate hydrogel for cell encapsulation
are not easily adapted for encapsulation of biologics. The
encapsulation process is time consuming.
[32]
Nanoencapsulation Celecoxib Amorphous drug/polymer nanoparticles containing
celecoxib were prepared using ethyl cellulose.
Nanoparticles released celecoxib rapidly and provided
higher dissolved-drug concentrations than micronized
crystalline drug. Nanoparticle suspensions were stable
for several days and can be spray-dried to form dry
powders resuspendable in water. Drug/polymer
nanoparticles are well suited for providing rapid oral
absorption and increased bioavailability of BCS Class II
drugs.
Absorption profile must be monitored as the
formulation showed enhanced bioavailability of the API




Novel carboxymethyl cellulose-chitosan hybrid
microparticles were prepared in aqueous media for
delivery of probiotic bacteria. The model probiotic
bacteria (Lactobacillus rhamnosus) was successfully
encapsulated in carboxymethyl cellulose based particles
with acceptable viability count for its potential delivery
in the intestinal tract with the purpose of modulating gut
microbiota and improving human health.
The microparticles produced must be protected from
environmental stresses i.e. heat
[34]
Table 1.






























polymeric microcapsules. Aceclofenac-loaded microcapsules was formulated using
ionic gelation technique employing sodium alginate as the coat material in combi-
nation with some mucoadhesive polysaccharide derivatives such as hydroxypropyl
methyl cellulose (HPMC), sodium carboxymethyl cellulose (SCMC) and methyl-
cellulose. The microcapsules were spherical (Figure 1) with microencapsulation
efficiency of 83.25–99.94%, good mucoadhesive property to enhance bioavailability
and ensured over 15 hr. sustained release of aceclofenac via zero order kinetic super
case 2 transport [19]. The formulation composition of drug:sodium alginate:HPMC
in the ratio of 2:4:1 displayed a sustained release of up to 24 hr. In another study
using aceclofenac, Dharmendra et al., [20] developed a LbL self-assembly which
was utilized to make aceclofenac single bilayer microcapsules produced by sequen-
tial adsorption of positively charged chitosan and negatively charged pectin, a
polysaccharide on the external surface of negatively charged aceclofenac micro-
crystals. This enabled targeted release of aceclofenac in the colon.
Glipizide an antidiabetic agent with short biological half-life was
microencapsulated using polysaccharide coat comprising alginate alone or in com-
bination with chitosan via ionotropic gelation process [35]. Abdelbary et al., [35]
showed that the microencapsulated glipizide enhanced drug bioavailability causing
significant hypoglycaemic activity compared to innovator product. Microencapsu-
lation provides a physical barrier against digestive enzymes, whilst offering protec-
tion against the acidic gastric environment. Cholesterol-lowering efficacy of
yoghurt formulation containing microencapsulated bile salt hydrolase (BSH)-active
Lactobacillus reuteri for management of hypercholesterolaemia adults was evaluated
by Martoni et al. [36]. Microencapsulation of bile salt hydrolase-active Lactobacillus
reuteri using sodium alginate showed superiority over traditional probiotic therapy
and may be an exceptional choice as a cholesterol-lowering agent to be administered
alone or in combination with other cholesterol-lowering agents [36].
Karan et al., [37] developed novel polymeric microspheres of 5-fluorouracil (5-
FU) using natural polysaccharide gum katira via microencapsulation to obtain an
optimal therapeutic response at the colon. This controlled release delivery system of
5FU released the chemotherapeutic agent at a controlled rate whilst retarding gas-
tric degradation of the drug. Utilization of natural polysaccharides in microencap-
sulation of 5FU via optimized katira gum microsphere ensured that a micro-carrier
for efficient colon drug targeting was developed.
Figure 1.
(a) SEM images of aceclofenac mucoadhesive microcapsules formulated with HPMC; (b) SEM images of
aceclofenac mucoadhesive microcapsules formulated with SCMC [19].
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The use of polysaccharides for microencapsulation of bicalutamide was utilized by
Tekade et al., [38] to develop bicalutamide microspheres using guar gum as a polymer
via oil-in-water emulsion solvent diffusion method. The microencapsulated dosage
forms containing 2.5% of guar gum, 0.25% span 80 as dispersing agent showed the
optimum drug release of 94.22% within 24 hrs, devoid of drug excipient interactions.
The potential to enhance bicalutamide bioavailability and sustained release especially
due to the polymorphic nature of the drug could be further optimized using
nanoencapsulation. This will create a channel for precision targeting of the non-
steroidal antiandrogen to a greater extent than microencapsulation [39] especially
where these microencapsulated solid dosage forms have not met the pharmacological
need of the patient.
Molecular Envelope Technology (MET) nanoparticles fabricated from complex
polysaccharide chains of N-palmitoyl-N monomethyl- N, N-dimethyl-N,N,N-
trimethyl-6-O-glycol chitosan, a self-assembling polymer amphiphile has been uti-
lized in delivery of formulations to target sites of action across the blood brain
barrier [40]. Fisusi et al., [40] developed drug loaded MET formulations containing
Lomustine for management of Glioblastoma multiforme. The MET envelope utiliz-
ing the complex polysaccharide for nanoencapsulation optimized biodistribution
and pharmacodynamics whilst reducing the toxic effects of the active drug,
lomustine thereby providing better outcomes for patients managed for brain can-
cer. As the active pharmaceutical ingredient is protected from degradation, the
MET envelope ensures targeted drug delivery due to PEGylation of the polysaccha-
ride to facilitate extended circulation time within the body [40, 41]. Lekshmi et al.,
[42] prepared and characterized repaglinide loaded ethylcellulose nanoparticles by
the solvent evaporation method for the management of type 2 diabetes. The poly-
saccharide encapsulated nanoparticles showed high encapsulation efficiency
suggesting that nanoencapsulation of repaglinide in biodegradable, biocompatible
polymer was able to improve its pharmacological activity via modification of sur-
face function and charge to promote cell entry.
Di Martino and co-workers fabricated polysaccharide-based polyelectrolyte
nanocomplexes which exhibited the several benefits of encapsulation [43]. Poly-
electrolyte nanocomplexes were formed between chitosan (CS) and alginic acid
(ALG) and then chitosan and polygalacturonic acid (PGA). Solutions of the
polycation (CS in acidic medium) and the polyanions (ALG and PGA in alkaline
medium separately) were prepared. The drugs, temozolomide (TMZ) and fluoro-
uracil (5-FU) were dissolved in aqueous solution and added to the separate solutions
of the polyanions. The drug(s)-polyanions solutions were added dropwise into
increasing concentrations of CS. Characterization of the encapsulated product
revealed spherical nanoparticles with diameters within 100–200 nm, increased
encapsulation efficiency with increasing concentration of CS, controlled release of
drugs, pH sensitivity making it a possible system for colon delivery, stability of
drugs especially TMZ. A setback is the burst release which may be due to several
factors such as drying method (freeze drying), and degree of complexation. This
setback can be modulated by adjusting the ratio of CS:ALG or CS:PGA, harvesting
of the nanoparticles early from the fabrication medium. Spray drying may be an
alternative to freeze drying to reduce migration of the drugs to the surface during
drying. In addition, derivatization of the polysaccharides without loss of their
polyelectrolytic nature may increase their mechanical strength, reduce pores within
and enhance entrapment.
Gastrointestinal intolerance of metformin HCl may be reduced by encapsulation
which provides controlled release of the drug ensuring therapeutic efficacy and
minimizing adverse effects. Extended release formulation became necessary to
improve patient adherence and reduce gastrointestinal intolerance (GI)
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experienced by the patients when on immediate release formulation [44, 45]. It is
envisaged the metformin HCl-loaded tamarind seed polysaccharide-alginate encap-
sulated beads fabricated by Nayak and co-workers [46] will control the release of
metformin HCl, improve GI tolerability and more. The drug release was pH sensi-
tive as less than 20% of metformin released in two hours while in acidic medium.
Most of the drug was released in pH 7.4, suggesting the maximal absorption may
occur in the duodenum and jejunum and possibly increasing the bioavailability of
metformin. The release of metformin followed a zero-order pattern which suggests
that metformin will be released at a constant rate thereby maximizing its therapeu-
tic efficacy and minimizing adverse effects.
2.3.2 Encapsulation of biologics
In a study undertaken by Sari and colleagues [47], chitosan was used as adjuvant
and encapsulating material for the formulation of an anti-botulism single shot
vaccine. The toxoids type C and D were encapsulated in chitosan by coacervation
method using sodium sulfate as the precipitating agent. The toxoids-loaded chitosan
microspheres were compared with the conventional method of mixing the toxoids
with aluminum hydroxide which served as an adjuvant. The protein encapsulation
efficiency obtained was 41.03% for toxoid C and 32.3% for toxoid D. It is envisaged
that modulation of parameters such as protein and chitosan concentration may
enhance the encapsulation efficiency. The comparative vaccination in guinea pigs
and the neutralization bioassay indicated that the animals were able to develop
titers of 10 and 2 IU/mL against C. botulinum type C and D respectively for both
toxoid-loaded chitosan microspheres and the conventional method of delivery.
However, aluminum hydroxide is fraught with adverse reactions such as local pain,
swelling, irritation at the injection site, erythema, subcutaneous nodules, contact
hypersensitivity and granuloma and allergic reactions [48, 49] making chitosan as
an adjuvant a better alternative. Chitosan enables humoral and cellular immune
responses and so it is efficient and safe compared to aluminum hydroxide [47].
Sodium alginate was used as an encapsulating material for the encapsulation of
mesenchymal stem cells (MSCs), a promising cell-based therapeutic agent for the
treatment of cancers, tissue injury, immune disorders, cardiovascular and neuro-
logical diseases [50]. MSCs were mixed with alginate solution and cell-encapsulated
alginate beads were fabricated by ionotropic gelation with calcium chloride as the
crosslinking agent. The cell-encapsulated beads were characterized to assess the
ability of the cells to execute their functions despite encapsulation. MSCs were able
to proliferate within the alginate beads at different times. Expression of genes
proceeded unhindered. In comparison to 2D cultured cells, the 3D (three-
dimensional microenvironment provided by the alginate microbeads) cells showed
a significant increase in expression of pro-angiogenic genes hypoxia-inducible fac-
tor-1 (HIF-1 – 80.4%) and VEGF (74%). Seven paracrine signaling factors such as
VEGF, TGF-β, TNF-α, IFN-γ, IL-10, IL-6, and IL-1β were secreted. There was an
indication that the 3D microenvironment could enhance pluripotency of MSCs. The
alginate beads facilitated proper growth and viability of MSCs contributing to the
higher therapeutic efficiency of MSCs in vivo. Encapsulated MSCs exhibited anti-
cancer activity against breast cancer stem cells, suppressed cancer-associated genes,
inhibited migration and angiogenesis of breast CSCs among other activities making
encapsulated MSCs a promising cell-based therapy for targeting cancer cells and
reducing the burden of cancer.
Insulin-loaded arabinoxylan microspheres were fabricated by crosslinking of
arabinoxylan employing enzymatic reaction and characterized [51]. Insulin solution
was prepared in 0.25 mM HCl and thereafter, glutamic acid was added, and pH
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adjusted to 4. The insulin solution was added to a solution of arabinoxylan in 0.1 M
acetate buffer and then agitated. The enzyme, laccase was added as the crosslinking
agent and dropwise extrusion into a hydrophobic liquid, and the microspheres were
formed and harvested after 6 hr. The insulin-loaded arabinoxylan microspheres
were characterized extensively in vitro and in vivo in diabetic induced Wistar rats.
Average size of the spherical shaped and smooth surfaced microspheres was 322 μm
having irregular pore sizes and geometries. Insulin aggregates in the microspheres
were stabilized by presence of glutamic acid yielding a homogenously distribution
of insulin. However, at higher insulin/arabinoxylan mass ratio, micro-phase sepa-
ration occurred. Arabinoxylan microspheres minimized release of insulin in the
gastric and small intestine facilitating delivery of insulin to the colon and limiting
degradation by the digestive enzymes. Controlled release of insulin over 10 hr. was
observed in vitro. For in vivo studies, insulin was first labeled with RITC before
encapsulation. It was observed that the insulin-RITC-loaded arabinoxylan micro-
spheres were relatively intact in the upper GIT releasing about 13–21% of the total
RITC load. Maximum amount of RITC was found in the colon, about 78.8% after
8 hr. possibly due to the degradation of arabinoxylan microspheres by the colonic
microflora. The blood glucose in the diabetic induced rats decreased by 70%
between 9 and 12 hr. after three treatments orally while hyperglycemia was
sustained in the control groups. Arabinoxylan microspheres protected insulin from
enzymatic degradation, retained a high percentage of insulin for delivery and
release in the colon exerting significant hypoglycemic effect.
Microneedle technology, an encapsulation technology used for biologics and
small molecules as an alternative to hypodermic injection and implantation was
used to encapsulate etanercept, for transdermal delivery for rheumatoid arthritis
[52]. Microneedles fabricated are microscopic needles of lengths 50–900 μm
(Figure 2) which pierces the stratum corneum barrier generating transient
microchannels for delivery of encapsulated biologic or small molecule without
triggering the nerves and injuring the blood vessels. Etanercept is a human dimeric
fusion protein which is fully soluble and is a tumor necrosis factor (TNF) inhibitor
as it binds to TNF preventing the activation of the inflammatory cascade. It is a
fusion protein of recombinant human TNF-receptor p75 fused with the Fc domain
of human Immunoglobulin G1 (IgG1).
Acrylate modified-hyaluronic acid was used to fabricate the microneedles and
on application to the skin released etanercept which was absorbed by the blood
capillary and etanercept was transported to the arthritic tissue where it exerted
therapeutic effect by binding to TNF (Figure 3). The etanercept-loaded
microneedles were fabricated by micromoulding method. Thereafter, the
microneedles were detached from the mold and crosslinked by exposing to UV light
to enhance mechanical strength. Drug loading and in vitro bioactivity were evalu-
ated. Skin penetration, microneedle dissolution and skin recovery, therapeutic
Figure 2.
Images of microneedles: (A) microscopic image – 500 μm, (B) microscopic image – 2 mm, (C) scanning electron
microscopic (SEM) image – 500 μm, and (D) SEM image – 100 μm [52].
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effect were determined with mice. Average etanercept per microneedle was
42.72  5.81 μg which was sufficient for in vivo evaluation. The microneedles
exhibited sufficient mechanical strength, complete dissolution of microneedles in
the skin after 90 min, quick recovery of skin after 120 min, good biocompatibility,
little interference with bioactivity of etanercept and high anti-inflammatory effi-
cacy. There was evidence of reduction of TNF-α and IL-6 in serum, protection of
the joint from erosion and microneedle system showed good bioequivalence to the
classical subcutaneous route.
Hydrogel encapsulation systems compare better than use of autologous
chondrocytes and the marrow stimulating technique for cartilage repair because
hydrogel encapsulation systems do not just encapsulate chondrocytes but also
maintain both cell viability and phenotype and support neocartiliage formation
[53]. Fenbo and co-workers [54] fabricated chondrocytes-loaded alginate-
chondroitin sulfate hydrogel beads by mixing solutions of sodium alginate and
chondroitin sulfate and chondrocytes was added to the mixture which was trans-
ferred dropwise into a solution of strontium chloride with a syringe. The beads were
harvested, rinsed to remove excess strontium chloride, and then cultured. Charac-
terization of the chondrocytes-loaded hydrogel beads showed that low molecular
weight alginate-chondroitin sulfate hydrogel promoted high cell viability and up-
regulated the expression of collagen II and B cell leukemia 2 (Bcl-2). The study
suggests that low molecular weight alginate-chondroitin sulfate hydrogel beads
promotes cartilage formation and decreases inflammation and may be a promising
system for cartilage tissue repair. The study observed that molecular weight of
encapsulating materials is an important parameter in tissue engineering.
2.3.3 Encapsulation of diagnostics
Encapsulation of biomarkers such as microRNAs (miRNAs or miRs) confer
stability on them. MiRNAs are a class of small endogenous non-coding RNAs com-
prising 18–22 nucleotides regulating various biological processes by preventing
expression of target genes [55, 56]. MiRNAs have been suggested and explored as
therapeutics and biomarkers for various diseases such as cancer, diabetes, cardio-
vascular diseases, and other diseases whose etiology is related to atypical gene
expression [57]. MiRNAs can be employed in disease environment for diagnosis,
treatment, and reoccurrence prediction. Moraes and colleagues [57] modified
pullulan by linking quaternized ammonium groups to its backbone. The pullulan
derivative interacted with miRNA to form stable polyplexes which were
Figure 3.
Schematic illustration of microneedle-assisted transdermal delivery of etanercept from application on the dorsal
skin of the mouse to binding of etanercept to TNF [52].
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characterized for physicochemical properties and cellular uptake. Elemental analy-
sis, SEC-MALLS analysis, and IR and NMR spectra confirmed the modification of
pullulan. Average size of polyplexes was 130  30 nm, zeta potential was
12  5 mV and morphology study showed homogenous spherical particles.
Agarose gel electrophoresis confirmed the presence of miRNA within the
polyplexes and loading efficiency was 80%. There was no indication of degradation
or fragmentation of miRNA suggesting that cationic quarternized pullulan could
protect miRNA. The polyplexes were found to be stable, cytocompatible, and the
complexation of miRNA with quartenized pullalan facilitated the uptake of
miRNA into the cells.
Cellulose nanofibers are appealing cargo carriers due the unique barrier, chem-
ical, interfacial, mechanical, and optical properties of nanocellulose [58]. Cellulose
nanofibers-based microcapsules were fabricated as a diagnostic device with glucose
oxidase encapsulated within for glucose monitoring [58]. Cellulose nanofibers
(CNF), apple pectin (AP) and xyloglucan-amyloid (XyG) were used to fabricate the
microcapsules using layer by layer ((LbL - CNF/XyG/CNF/AP)2CNF) technique on
top of fluorescein isothiocyanate (FITC) – labeled glucose oxidase-loaded calcium
carbonate particles to build the capsule wall. The FITC-glucose oxidase-CaCO3
particles were crosslinked with glutaraldehyde forming the templates on which LbL
microcapsules were fabricated. After LbL fabrication, calcium carbonate was
removed with 100 mM EDTA in water. The microcapsules collapsed on drying after
removal of the CaCO3 core. The glucose oxidase-loaded microcapsules fabricated
were porous, spherical, uniform and structurally stable, and the encapsulation
efficiency of glucose oxidase was 68  2%. The microcapsules were used to moni-
tor/measure glucose. An interaction of glucose oxidase and glucose produced
hydrogen peroxide which was transported through channels to an external flow-cell
where hydrogen peroxide was oxidized electrically producing current that was
recorded and used to determine the concentration of glucose. The microcapsules
immobilized the enzymes as well as provided a favorable microenvironment for the
sustained biocatalytic activity of glucose oxidase. The nanocellulose microcapsules
show promise as a device for in vivo monitoring of analytes.
A glucose biosensor fabricated based on gum tragacanth was tested on actual
blood samples. Cadmium Telluride Quantum Dots (CdTe QDs) and glucose oxidase
were encapsulated in tragacanth gum for glucose detection [59]. Tragacanth gum
nanohydrogels were prepared by adjustment of pH, sonication followed by precip-
itation. Modified tragacanth gum was prepared by radial graft copolymerization of
acrylic acid (AA: 0–5 mL), using N,N0-methylenebisacrylamide (MBA: 0.1–0.3 g) as
a crosslinker in potassium persulfate solution (initiator) followed by precipitation
after agitation for 4 hr. at 70°C. The nanohydrogels were characterized and the
composition with the desired mechanical strength and highest swelling ratio was
used in fabrication of superabsorbent biosensor nanohydrogels. The biosensor
nanohydrogels were tested for leakage of CdTe QDs and glucose oxidase, encapsu-
lation efficiency and glucose detection. The QDs leakage was about 1.48% for 2 hr.
There was insignificant change in fluorescence intensity of QDs after 45 days at 4°C
and 17% decrease in fluorescence intensity at ambient temperature after 45 days.
Enzyme was stable at 4°C and unstable with time at ambient temperature. Fluores-
cence intensity decreased significantly with increase in hydrogen peroxide concen-
tration indicating the encapsulated glucose oxidase was able to catalyze the
oxidation of glucose to hydrogen peroxide and gluconic acid.
Enzymatic reaction, base stacking (aptamers) and antigen–antibody linkers are
possible approaches to cholesterol detection; however, they are fraught with some
limitations and foreign interference [60]. Chebi and co-workers [60] fabricated a
nano-sensor for cholesterol sensing without enzymatic reaction using curcumin
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(CUR) as a fluorescence probe, polyelectrolyte, chitosan oligosaccharide lactate
(COL) as the encapsulating material and silica nanoparticles as the core (Figure 4).
The nanohybrid particles were fabricated by precipitation technique. Solutions of
COL and curcumin were mixed under agitation and a dispersion of silica
nanoparticles was added dropwise and agitated overnight. The nanocapsules
formed were harvested and characterized. When not aggregated, the sizes of the
spherical particles were 25–35 nm. In the presence of cholesterol, a large blue shift ˃
100 nm was observed in the fluorescence intensity of nanohybrid particles. The
fluorescence intensity of the nanohybrid particles were not affected by interfering
substances such as ascorbic acid, uric acid and glucose indicating specificity, selec-
tivity and sensitivity of cholesterol determination using the fabricated nano-sensor.
Urea is a waste product of metabolism and is eliminated from the body through
the kidney. Evaluation of urea content is used to assess kidney function and other
possible implications. Increased level of urea in the urine and blood indicates the
presence of some acute and chronic diseases such as kidney failure, and myocardial
infarction, or dehydration, gastrointestinal hemorrhage, high protein diet, aging
and catabolic states such as trauma, severe infection, starvation and drugs.
Decreased urea content is indicative of pregnancy, low protein diet, overhydration,
advanced liver disease and reduced urea synthesis. While there are several tech-
niques for determining urea content, there is a growing need for easy to fabricate,
easy to use and cheap diagnostic tools. Khattab and co-workers [61] fabricated
crosslinked calcium alginate microcapsules containing urease and tricyanofuran
hydrazone fixed on cotton fibers to create a colorimetric cotton strip as a sensor for
determining urea content. Solutions of sodium alginate, urease and tricyanofuran
hydrazone was mixed and overlaid on cotton fiber strips and dried. Thereafter the
dried cotton fiber strips were immersed in a solution of calcium choride for the
crosslinking process. The microcapsules were characterized, and the sensor was
used to determine urea content. The urea content assay using the sensor fabricated,
displayed a visual color change from light yellow to purple indicating the presence
Figure 4.
Schematic illustration of the fabrication of nanohybrid particles and the fluorescence intensity in the presence of
cholesterol.
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Micro-encapsulating materials Active compounds Micro-encapsulation technique Application EE % Ref.
Polysaccharide Other materials
Gum katira 5-fluorouracil Emulsion solvent evaporation Treatment of colon cancer 59.45  3.18–79.25  4.25 [37]
Guar gum Bicalutamide Emulsion solvent diffusion Treatment of prostate cancer 69.43  1.06–74  1.07 [38]
Tamarind seed polysaccharide/alginate Metformin HCl Ionotropic gelation Diabetes 94.86  3.92 [46]
Arabinoxylan Insulin Enzymatic crosslinking Diabetes — [51]





Inflammation, pain 74  1 [62]
Gellan gum Methotrexate Emulsion solvent diffusion
method
Cancers and auto-immune diseases 50.78–84.8 [63]
Esterified Agave Fructans Ibuprofen Coacervation Inflammation, pain 0.8–21.5 [64]
Chitosan Astragalus Polysaccharide Spray-drying Allergic rhinitis [65]
Galactomannan (Delonix regia) pluronic® F127 Riboflavin Spray-drying Energy conversion, growth of cells
and health of eyes and skin
87.14–88.53 [66]
β-glucan Anthocyanins Spray-drying Antioxidant/therapeutic 45 [67]
psyllium husk mucilage Curcumin Precipitation Antioxidant, antifungal and
antibacterial
56 [68]
Cyanobacterial polysaccharide Vitamin B12 Spray drying Cell metabolism, blood cell
production
[69]
Pectin-Alginate Vitamin E Emulsification-ionic gelation Antioxidant 52.91 [70]
β-cyclodextrin Caffeine Freeze drying Psychostimulant 74 [71]
Sodium alginate Urease/tricyanofuran hydrazone Ionotropic gelation Urea detection 38.5–55.5 [61]
Table 2.





























Nano-encapsulating materials Active compounds Micro-encapsulation techniques Applications EE % Ref.
Polysaccharide Other materials





Ethyl cellulose Repaglinde Solvent evaporation Diabetes Mellitus 58.8  0.724–
86.4  0.31
[42]
Chitosan/alginic acid Temozolomide/fluorouracil Polyelectrolyte complexation Cancer 43  3–76  8 [43]
Pullulan derivative miRNA Polyelectrolyte complexation Gene delivery/biomarker 80 [57]
Cellulose/pectin/xyloglucan Glucose oxidase Layer by layer Glucose detection 68  2 [58]
Tragacanth gum Acrylic acid Glucose oxidase/cadmium telluride
quantum dots
Copolymerization-precipitation Glucose detection [59]
Chitosan oligosaccharide lactate Silica Curcumin Precipitation Cholesterol detection [60]
Auricularia auricular
polysaccharide/chitosan
Doxorubicin HCl Polyelectrolyte complexation CANCER 74.1  2.2 [72]





Doxorubicin Polyelectrolyte complexation Cancers 55–64.2 [74]
Mango gum Donezepil Emulsion crosslinking CNS - dementia 85  2.14 [75]
Azivash gum Polyvinyl alcohol Catechin Electrospinning Antioxidant 87.4–99 [76]
Cashew gum N-isopropylacrylamide Epirubicin Self-assembly Cancer 63.67  1.4% [77]





Zeaxanthin Nano emulsification Antioxidant 96.57 [79]
Table 3.




















































of urea. The detection ability of the sensor was determined by the color strength
and the International Commission on Illumination – CIE L*, a⁎, and b⁎ color coor-
dinates. The dye and enzyme-loaded crosslinked alginate microparticles coated
cotton sensor strips were effectively employed to determine unknown concentra-
tions of urea. The spectroscopic parameters indicated the microencapsulated sensor
displayed a detection range of 0.1 ppm to 250 ppm. Tables 2 and 3 indicate appli-
cations based on micro- and nano-encapsulation utilizing natural polysaccharides as
encapsulating materials.
3. Protein-based encapsulation
3.1 Proteins in micro- and nanoencapsulation
Protein-based delivery systems can be synthesized via different kinds of animal
and plant proteins using a range of different production methods. A fabricator
should pick the most fitting protein for a certain application, after making sure of all
safety requirements. The main elements influencing the selection of the protein and
encapsulation methods are:
a. Nanocarrier chemical or physical compatibility with food components.
b. Nanocarrier stability under processing, storage, or during its application.
c. Possible release mechanism(s) and conditions affecting the rate of release.
d. Biodegradability of the protein-based nanocarrier in the body.
e. Cost-effectiveness of nanocarriers when synthesized on a large scale for real
applications.
Figure 5 is a schematic illustration of polymeric encapsulation of bioactive
agents.
3.1.1 Applications and clinical usage
Protein-based nanoparticles (PBNs), recently reported, are of great interest due
to their various advantages. They confirmed their high activity in both clinical and
medicinal fields. Several formulations have been developed and suggested as
potential future therapeutic products [80]. Besides, some PBNs have been officially
accepted by US food and drug administration [81]. In addition, protein-based
nanoparticles functional groups (e.g. carboxylic and amino groups) facilitate the
particles surface modification, which makes them suitable for tumor targeting
strategies. On the other hand, protein-based nanoparticles (PBNs) surface can be
modified by attachment of targeting ligands such as peptides, antibodies, vitamins,
hormones, and enzymes. These surface modifications allow specific targeting and
accumulation of the particles at the desired site such as a tumor. Each protein tends
to encapsulate either hydrophobic or hydrophilic molecules. Gelatin, silk, gliadin,
and legumin have higher encapsulation efficiency for hydrophilic drugs. While
collagen, casein, and zein proteins have higher encapsulation efficiency for hydro-
phobic drugs. Albumin, however, can bioconjugate with hydrophilic drugs and
interact with highly hydrophobic drugs. Besides, each protein has some character-
istics that enhance its selectivity to be a better carrier for a certain drug. Albumin,
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for example, is the most abundant plasma protein, which makes it non-toxic,
biodegradable, and non-immunogenic. It has also good connectivity to many drugs
and it is extremely robust to various conditions. Gelatin and collagen possess many
carboxyl groups with possible crosslinking functions. These parameters are impor-
tant for selecting the nanoparticles synthesis method. The protein selection depends
on drug properties, and on the target of the nanoparticles to be prepared. The
selected protein properties such as functionality, molecular weight, and hydropho-
bicity can affect particle size, drug loading and loading efficiency, and dissolution
or release profile of the drug to the surrounding environment of the nanoparticles.
The proteins have the chance to target a specific place in vivo and secure the
encapsulated active molecules from biodegradation and undesirable metabolism -
Figure 6. Protein nanoparticles, however, have unique properties when compared
to other nanoparticles since they are extracted from natural origins that exist in
nature, easy to handle, and most importantly they are non-toxic as they do not leave
undesirable biodegradation products.
3.1.2 Physicochemical properties of proteins
The physicochemical properties of proteins such as isoelectric point (pI), chemical
compositions, denaturation thermal temperature (Tm), and solubility are necessary
for the fabrication of the protein-based micro- and nanoencapsulation delivery sys-
tems (Table 4) [82–90]. Some micro- and nanoencapsulation processes use protein
as a wall material to act as a barrier which is used to protect bioactive agents against
the surrounded environmental conditions including pH, temperature, moisture, and
oxygen and form stable capsules (they are in a range size between few micrometers
and millimeters in microencapsulation methods and from 10 nanometers to one
micrometer in nanoencapsulation methods) with high encapsulation efficiency (EE)
due to their excellent gel, film and emulsifying formation properties, and promising
improvements such as water solubility, stability, and bioavailability [91, 92]. Besides,
Figure 5.
Schematic illustration of encapsulation of bioactive agents.
Figure 6.
Drug loading and release from protein-based nanoparticles.
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their functional groups possess the ability to protect, reverse binding, and interact
with numerous bioactive compounds. Nowadays, two sources of proteins; plant pro-
teins such as soy, pulses, and cereals proteins and animal proteins such as bovine
serum albumin, casein and whey proteins are widely used as encapsulating agents in
micro- and nanoencapsulation techniques. Proteins are employed to encapsulate
solids and liquids including oils. Their ability to encapsulate oils depends on their
capacity to adsorb at the interface and form stable emulsions. The following factors
affect their emulsifying properties [93]:
• The molecular size of proteins
• Hydrophobicity of the protein surface
• The flexibility of protein compounds
• Protein solubility
Protein Source Main composition Properties pI Tm (°C)
1.1. Soy
protein

































Water soluble 4.5 90
1.3.3. Lentil Lentil Globulins, albumin,
glutelins, and prolamins




























583 amino acids and





2.4. Gelatin Collagen Acid (Type-A) gelatin and
basic (Type-B) gelatin
Linear, soluble in hot
water, and highly stable
4.8 40
pI: Isoelectric point and Tm: denaturation thermal temperature.
Table 4.
Physicochemical properties of plant and animal proteins used for the delivery of bioactive ingredients.
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• Preparation methods of protein compounds
• Environmental conditions include pH of solvent and ionic strength
Protein ingredients have been vastly used as good encapsulating agents alone or
in combination with either another protein or polysaccharides which occurs
through different possible interactions (such as covalent, electrostatic, H-bonding,
hydrophobic, van der Waals, and disulfide interactions) for delivery of various
bioactive compounds (Figure 7) [94]. Different polysaccharides can be used to
fabricate bilayer on the oil droplets surface with protein compounds to increase the
physical stability of both emulsion and the interfacial modifying properties [95].
3.1.3 Plant proteins
Plant proteins have different types such as soy proteins, cereals proteins (e.g., zein,
wheat, andbarley proteins), andpulses proteins (e.g., pea, chickpea, and lentil proteins).
3.1.3.1 Soy proteins
Soy proteins are globular proteins and are considered as one of themost important
food proteins that are applied significantly in human diets because they have good
nutritional values, health-benefiting effects, and high functionalities. They aremainly
composed of albumins and globulins which represent around 50–90% of total seed
proteins. They are divided according to their sedimentation coefficients into four
fractions: 2S, 7S, 11S, and 15S fractions. The 2S fraction corresponds to albumins, while
the globulins are present in 7S, 11S, and 15S fractions. Also, glycinin (named as 11S or
SG, andMwt 350 kDa) and β-conglycinin (named as 7S or SC, andMwt of about 70 kDa
are two globulin forms). Soy protein isolate (SPI) is considered as an essential product
of soy proteins and contains protein range from85 to 90%as a dry basis [96, 97]. Due to
the good properties of soy proteins such as water solubility, fat andwater absorption,
gel, film, and foaming-formation and emulsion stabilization properties, they have been
used as wall materials for micro- and nanoencapsulation of different bioactive ingredi-
ents alone or in combination with either proteins or polysaccharides [98].
3.1.3.2 Cereal proteins
Cereal grains are grown worldwide and they comprise three main biopolymers
which are roughly classified into three groups - protein, starch, and non-starch
polysaccharides [99]. Cereal micro- and nanotechnology for biomedical, food, and
pharmaceutical applications focus on fabricating highly functional micro- and
nanostructures from cereal biopolymers. Cereal proteins (e.g., zein, barley, and
wheat proteins) are considered a vital protein source in the diet. Cereal proteins
have excellent properties such as low cost, widely available, and versatile molecules
which are valuable compounds for nano- and microtechnology applications. They
are classified into four classes according to the solubility of fractionations: (a)
albumins; proteins soluble in water, (b) globulins; proteins soluble in the diluted
salt solution, (c) prolamins; proteins soluble in the aqueous alcohol, and (d)
glutelins; proteins soluble in the diluted acid or alkali [100, 101].
3.1.3.3 Maize (Zein) protein
Zein protein is classified as a storage prolamine protein that makes up 35–60% of
total protein in corn (maize). Pure zein protein is one of the important plant
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proteins due to its properties such as clear, tasteless, odorless, and edible properties,
making it widely used a protein in different industrial applications [102]. The main
composition of zein proteins is amino acids such as glutamic acid, leucine, alanine,
and proline that are combined via disulfide bonds. It has four fractions: α, β, and γ as
major fractions (accounts for 80% of the total zein protein), while the last one
named δ-zein is a minor fraction. α-Zein protein is the main zein type commercially
available in the market. It is water-insoluble because of the presence of non-polar
amino acids which are previously mentioned but is soluble in the aqueous alcohol
(50–95%). Its poor solubility in water due to the absence of essential amino acids
including tryptophan and lysine decreased its usage in food products for human
consumption, so zein protein nanocarriers have been applied to encapsulate core
materials to enhance their distribution in water environment [103, 104]. Prolamine
protein as zein protein is a valuable compound used to prepare micro-and nanoscale
systems that are stable in water because these systems do not need a post-
Figure 7.
Suggested interactions in two biopolymers components (e.g., protein and polysaccharide) system.
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production hardening step that stables the integrity of prepared particles, as the
constituting protein does not require to re-dissolve in water [105].
3.1.3.4 Wheat proteins
Wheat proteins are obtained during the isolation of starch polysaccharide from
wheat flour as a byproduct and account for 80% of total wheat seed proteins; it is
also used as an essential food source for both humans and animals [106]. Wheat
flour is a complex material which composes of small polysaccharide fraction as
starch and protein. The latter composes of two main components as gliadin and
glutenin. The constitution of gliadin is single chain polypeptides (average molecular
weight, Mwt, ranged from 25 KDa to 100 KDa) which are linked by intramolecular
disulfide bonds and soluble in the aqueous alcohol (70% ethanol), while glutenin is
a soluble fraction and is similar to gliadin composition but they are linked via
intermolecular disulfide bonds with Mwt higher than 105 KDa [106, 107]. Wheat
proteins have different interesting physicochemical properties such as gel- and
film-forming properties due to its low water solubility and viscoelasticity [108].
3.1.3.5 Barley protein
Barley crop is a very adaptable crop. It is cultivated for both animal feed and
brewing industry, in which, the by-product becomes livestock feed. Barley crops and
by-products are rich and affordable protein sources which include 8–13% and 20–30%,
respectively [109]. Barley proteins composed of two major protein fractions: hordein
and glutelin (about 35–55% and 35–40%, respectively). Hordein fraction (alcohol
extracted fraction) is divided into five groups - B hordein, C hordein, γ-hordein, D
hordein, and A hordein - based on their amino acid compositions and electrophoretic
mobility. On the other hand, glutelin is an alkali-soluble protein after hordein extrac-
tion, so it is not possible to extract glutelin fraction free from hordein fraction con-
tamination. Barley proteins are highly hydrophobic and they exhibit excellent foaming,
emulsifying and film-forming properties indicating that the emulsifying-stabilization
process can prepare micro- and nanocapsules from barley protein [110–112].
3.1.3.6 Pulse proteins
Pulse crops are invaluable agricultural commodities that are grown in cool seasons
annually. They are grown in many regions around the world such as North America
(particularly Canada), Asia, and the Middle East (particularly India and Egypt). They
are considered an important source of dietary protein, fiber, essential vitamins, min-
erals, and carbohydrates. So, they have a health value that relates to decrease of HDL
cholesterol, heart disease, and type-2 diabetes. The pulse proteins including lentil, pea,
and chickpea proteins which show an attractive alternative to soy proteins because
they have a low risk for allergen and non-genetically modified status [113, 114]. Pulse
proteins are classified according to their solubility into glutelins (dilute acid and
alkaline-soluble and makes up 10–20% of the total pulse protein), globulins (soluble in
water-salt solution and accounts for 70% of the total pulse protein), and albumin
(water-soluble and represents about 10–20% of the total pulse protein) [113].
3.1.3.7 Pea protein
Pea protein is extracted from pea seeds which represents 18–30% fraction. It is
mainly composed of globulins (65–80%) that include three various proteins:
legumin, convicilin, and vicilin [115]. Also, it contains albumins and glutelins as two
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minority fractions. Pea legumin protein (denoted 11S globulin) has molecular
weight ranged 350–400 KDa while convicilin and vicilin (denoted 7S globulin) have
a molecular weight of about 150 KDa [98]. Pea proteins have interesting emulsify-
ing and gel-forming properties, so they are used alone or in combination with either
proteins or polysaccharides. This interaction creates a stable emulsion that improves
the efficiency of a micro/nanoencapsulation technique as it gives good particle size
distribution. Also, encapsulation occurs without chemical or enzymatic modifica-
tion, due to the surfactant, foaming, and solubility properties. Besides, they are
cheap and highly nutritious [116, 117].
3.1.3.8 Chickpea protein
Chickpea protein possesses many excellent advantages such as low cost, biode-
gradable, biocompatible, and non-toxic, hence, its use in the encapsulation field.
Moreover, it is generally safe for use in the food industry because of little or no
toxicity and side reactions [118–120]. Chickpea protein contains glutein, albumin,
prolamine, and globulin with different percentage contents as the main composition:
3.12–6.89%, 8.39–12.31%, 19.38–24.40%, and 53.44–60.29%, respectively, and repre-
sents about 28.6% of total chickpea crops [121, 122]. It is a low-cost wall material and
possesses high encapsulating ability, emulsifying properties, nutritional value, and
beneficial health effects. Additionally, it can form thick viscoelastic films around oil
droplets thus enhancing their stability through processing. The chickpea protein is
widely used in different culinary applications because it has sustained nutritional
benefits, and it is used in stews, soups, and salads [84, 93, 123, 124].
3.1.3.9 Lentil protein
Lentil crops are implanted in over 48 countries around the world and they
contain soluble and dietary fiber more than in both pea and chickpea crops, besides,
they are rich in protein sources which ranged from 20.6–31.4% of the total lentil
plant. Lentil protein comprises globulins (Mwt 320–380 KDa), albumin (Mwt20
KDa), glutelins (Mwt 17–46 KDa), and prolamins (Mwt 16–64 kDa) with different
percentages: 70%, 16%, 11%, and 3%, respectively [125–127]. It has good properties
such as good solubility, drying, and emulsifying properties that lead to being widely
used as a wall material to form stable capsules with high EE % [128].
3.1.4 Animal proteins
Animal proteins are amphiphilic compounds because they compose of block
copolymers with both hydrophilic and hydrophobic amino acid residues. There are
various types of animal proteins such as milk proteins: whey proteins and casein,
gelatin, and bovine serum albumin which can be used in micro- and nanoencap-
sulation processes as wall materials either alone or in combination with other bio-
polymers: proteins (as soy protein) and polysaccharides (as chitosan) [91, 129].
Also, they possess many advantages more than plant protein as good wall materials
as summarized below:
• More soluble than plant proteins over the wide pH range,
• Lower Mwt than plant proteins (e.g., soy protein has Mwt: 350 kDa, while
casein protein has Mwt: 20 kDa)
• More flexible.
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3.1.4.1 Milk proteins
Milk proteins can be divided into two groups: casein and whey proteins which
can bind their hydrophilic and hydrophobic moieties with different substances with
various affinities [130]. They are considered a good choice for micro- and
nanoencapsulation of bioactive materials as wall materials due to their physico-
chemical properties. They are available commercial products, they are flexible
materials to encapsulate hydrophilic, hydrophobic and viable bioactive compounds,
and they are rich bioactive peptide sources of various physiological effects. Also,
they have a variety of characteristics including pH-responsiveness, self-assembly,
and gel swelling behavior that lead to their use as good candidates for bioactive
delivery systems [91, 131, 132].
3.1.4.2 Whey proteins
Whey proteins are produced from the manufacture of either cheese or casein as
the dairy byproduct. They compose of a mixture of β-lactoglubulin, α-lactalbumin,
and serum albumin which are water-soluble, so they have a variety of applications
[133]. They are considered complete proteins because they have nine essential amino
acids, in addition, low in lactose content. The three forms of whey protein are:
• Whey protein concentrate (WPC) which contains low fat and carbohydrate
levels. The protein percentage in WPC is ranged between 30% and 90%.
• Whey protein isolate (WPI) which contains zero fat and lactose contents, and
it contains high protein level (≥ 90%)
• Whey protein hydrolysate (WPH) which has been subjected to partial
hydrolysis process. So, it is a predigested form of whey protein.
Whey proteins are widely used as good wall coating materials in micro- and
nanoencapsulation processes for the controlled release of different bioactive mate-
rials such as oils/fats, vitamins, and volatile compounds because of the high
encapsulation efficiency and stability during storage [134–137].
3.1.4.3 Casein proteins
Casein is a major amphiphilic milk protein (it makes up about 80% of total milk
protein) which is an essential part of the global daily diet. It has a variety of
interesting physicochemical properties such as its availability, low-cost, non-
toxicity, high stability, biocompatibility, biodegradability, binding of small and ions
molecules, excellent emulsification, and self-assembly that increase its efficacy in
both encapsulation and loading efficiency of the loaded bioactive ingredients
[130, 138]. Casein protein’s composition is 94% protein and 6% low Mwt colloidal
calcium phosphate. There are four different casein fractions: αS1-, αS2-, β, and
κ-casein which are amphiphilic structures in proportions of 4:1:4:1 by weight,
respectively. Mwt is ranged from 19 kDa to 25 kDa [139–141]. Casein micro- and
nanoencapsulation carrier systems have attracted attention in recent years for
controlled and sustained release delivery of bioactive compounds because of the
following advantages: their cheap price, digestibility, good dispersibility in an
aqueous system, good amphiphilicity, the capability to encapsulate a variety of drug
and nutrients, and form uniform spherical structures [142–144].
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3.1.4.4 Bovine serum albumin
Bovine serum albumin (BSA) is a globular natural albumin protein. Its origin is
either bovine serum or milk which is transferred between bovine plasma and milk
through the lactating cells [131, 145]. Its structure composes a single chain of 583
amino acids with Mwt of 62.2 kDa and contains three domains: I, II, and III which are
divided into two helical subdomains (A and B which bond through 17 disulfide brid-
ges) which is specified to bind lipid, nucleotide, and metal ion [130, 146, 147]. Addi-
tionally, BSA is negatively charged at physiological pH (pH 7.4). Moreover, BSA is one
of the most common protein plasma that is widely used in many applications such as
drug and antigen delivery and food industry because it has good features: biocompat-
ibility, biodegradability, non-toxicity, no immunogenicity, good stability, low cost,
abundance, ease of purification and unusual ligand-binding. Consequently, its micro-
and nano-capsule carriers have gained traction in recent years [145, 148].
3.1.4.5 Gelatin protein
Gelatin protein is not available in nature, but it is extracted from partially
hydrolyzed collagen which is the most abundant protein in the skin and bones of the
animal bovine or fish. Also, it is a linear denatured protein which is carrying dual
charges: positively charged (when it is extracted with acid hydrolysis of collagen, it
is known as type –A gelatin and its pI is ranged 7–9.4) and negatively charged (if it
is extracted with alkaline hydrolysis, it is known as type –B gelatin and its pI is
ranged 4.8–5.5) and its thermal denaturation temperature is about 40°C [149, 150].
In addition, gelatin protein is a good coating material due to its amphoteric nature,
and so it is widely used as coating materials in combination with different poly-
saccharides such as chitosan, pectin, and alginate to form hard and soft capsules (in
range of micro- and nanoscale) in food and pharmaceutical applications [151–154].
3.2 Merits and demerits in therapeutic delivery
The link of a drug with a delivery system is named “controlled drug delivery”.
This link can control drug pharmacokinetics. Various delivery systems were
aroused. Among them, we can cite nanoparticles, liposomes, surface-modified
nanoparticles, and solid-lipid nanoparticles. Among nanoparticles, protein-based
nanoparticles (PBNs) have special merits because they are metabolizable, biode-
gradable, and can be easily controlled as there are different chances for surface
improvement for drug fixation [155].
Many proteins have functional merits making them suitable for encapsulation of
bioactive agents, such as pharmaceuticals and nutraceuticals. Natural proteins are
biological polymers composed of amino acid chains linked together via peptide
bonds, which serve in important biological functions, such as enzyme catalysis,
signaling, transport, and structure formation [156]. Some of the proteins’ chemical
and physical characteristics can be used to construct encapsulation and carrier
systems. Proteins used in the nanoparticles field can be classified as animal proteins
and plant proteins, and both have advantages and disadvantages.
Low toxicity of the end product using animal proteins gives them an advantage
over synthetic polymers. Themajor drawback of animal proteins is the risk of infection
from any pathogenic contamination, although, it is not important as animal proteins
can be disinfected. As for plant proteins, their hydrophobic character is the main
advantage compared to animal proteins. This could lead to avoiding toxic chemical
cross-linkers [157]. Besides, plant proteins are also cheaper than animal proteins.
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3.3 Case studies/applications
3.3.1 Encapsulation of small molecules
3.3.1.1 Hydrophobic compounds
It is used with hydrophilic compounds to improve stability and bioavailability of
certain compounds such as lipid vitamins (eg: A, D, E, and K). Vitamin A (VA) and
VE were also successfully incorporated into biodegradable gelatin nanofibers.
Curcumin is a fat-soluble polyphenol that possesses significant antioxidant and
anticarcinogenic activities [158]. The release profile showed sustained release
behavior of curcumin for over 7 days (around 75%) without significant burst effect
when curcumin was encapsulated within amaranth protein isolate (API)/pullulan
nanofibers. Dextran and whey protein concentrate (WPC) and chitosan were used
as matrix materials to encapsulate lycopene by emulsion electrospinning. WPC
afforded the greatest EE (around 75%), and it was also able to protect lycopene
against moisture and thermal degradation [158]. Zein nanoparticles were used as
delivery nano-system to enhance the oral bioavailability of quercetin (3,30,40,5,7-
pentahydroxyflavone), which is found in tea, red wine, fruits, and some vegetables.
Zein is a protein extracted from corn (with molecular weight usually from 22 to
27 kDa). It has a high content of hydrophobic amino acids, such as proline, gluta-
mine, and asparagine. The encapsulation of quercetin ameliorates its anti-
inflammatory effect on endotoxemia was studied in a mouse model [159]. Okagu
et al., [160] studied the encapsulation of hydrophobic nutraceuticals (curcumin) by
biopolymer nano-complexes based on insect proteins as uncoated or coated with
chitosan. The authors explained the interaction between curcumin and insect via
hydrophobic forces. They observed under gastrointestinal conditions, over 90% of
the nutraceutical was released. Hu et al. [161] formed biopolymer-based
nanoparticles through ionic gelation between stearic acid-chitosan conjugate (SA-
CS) and sodium caseinate (NaCas) and cross-linked using oxidized dextran (Odex)
via Schiff base reaction, as shown in Figure 8. The prepared nanoparticles were
used to encapsulate Astaxanthin (ASTX) to improve its bioavailability and solubil-
ity in an aqueous medium. The authors successfully prepared nanoparticles with a
diameter of 120 nm with good dispersity. They estimated the capability of loading
ratio of 6% loading ratio and high efficiency of encapsulation.
Xiang et al. [162] formed nanocomplexes composed of ovalbumin (OVA) and
methoxy pectin (PEC) to encapsulate Vitamin D3 (VD3). Vitamin D3 is fat-soluble
and readily degrades under acidic conditions. The authors observed the efficiency
of VD3 encapsulation up to 96.37%. Whey proteins (positive proteins) (4% w/w),
and pectin (negatively charged polysaccharides) (1% w/w) were used to form
nanocomplexes which were used to encapsulate D-limonene [163]. Resulted
nanocomplexes have spherical shaped nanoparticles with an average diameter of
100 nm. The efficiency of D-limonene encapsulation was about 88%.
3.3.1.2 Hydrophilic compounds
Hydrophilic compounds are encapsulated to prevent their interactions with
different compounds or to guarantee a certain release pattern. A study was under-
taken to assess the release kinetics of prepared nano-encapsulated folic acid using a
double W1/O/W2 emulsion [164]. Initially, loaded W1/O nano-emulsions with folic
acid were formed and then re-emulsified into an aqueous stage (W2) having a
concentrate on a single whey protein (WPC) layer or double-layered complex of
WPC-pectin for W1/O/W2 emulsions formation. Single-layer WPC encapsulated
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powders was the best model that fits for folic acid release pattern observed with the
highest R2. Enzymes are particularly important in therapeutics because of their
catalytic activity and specificity. The challenge in the intracellular delivery of
enzymes is that enzymes are unstable and have a huge size. Estrada et al. [165]
developed β-Galactosidase delivery nanoparticles based on a protein. β-Galactosi-
dase (β-gal) is an important enzyme, and its deficiency leads to several lysosomal
storage disorders. The authors observed that protein-enzyme nanoparticles showed
internalization in multiple cell lines in vitro higher than soluble enzyme. Authors
based on the result concluded that protein nanoparticles are a biocompatible and
display good efficiency for active enzyme therapeutics delivery.
3.3.2 Encapsulation of biologics
Noorani et al. [166] fabricated albumin nanoparticles enhancing anticancer effi-
ciency of albendazole in the xenograft model of ovarian cancer. Nanoparticles based
albumin was formulated with the diameter in the range of 7 to 10nm. Loaded
albendazole onto albumin nanoparticles showed the highest killing effect with
specificity against ovarian cancer cells studied ex vivo [167].
Trafani de Melo et al. [168] studied the design of whey protein drug delivery
system for a photoactive compound, aluminum phthalocyanine chloride for
targeting of glioblastoma brain cancer. Nanoparticles were fabricated by spray
drying technique with particle size between 100 and 300 nm. Authors based on
their results concluded that a combination of hydrophobic drugs and irradiation
achieve efficient treatment.
Stein et al. formulated mTHPC-albumin nanoparticles using nab-technology
[169]. Nanoparticles showed colloidal stability over a wide range of pH and in
physiological NaCl with different concentrations. The authors observed cell culture
uptake of mTHPC in a cholangiocarcinoma cell line (TFK-1).
3.3.3 Encapsulation of diagnostics
Nanoscale materials permit nanodevices to enter novel scientific and technolog-
ical frontiers in different diseases especially cancer diagnosis. Proteinticles are
nanoscale protein particles designated by engineering, which are very useful in
changing different properties based on surface area and size of various conventional
things [170]. Combined detection of two serum biomarkers is also feasible through
multiplexed viral detection. The disease detection method is imperative in diseases
such as AIDS and hepatitis. Such a protocol is based on lateral flow assay (LFA) for
protein nanoparticles. Proteinticles were found to have better biocompatibility and
biodegradability with compliance with surface modifications. These nanoparticles
are formed by using different proteins like elastin, gliadin, gelatin, zein, legumin,
Figure 8.
General mechanism of ASTX loaded SA-CS/NaCas/Odex nanoparticles formulation and its application.
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albumin, soy protein, and milk protein. Various methods used for the formulation
include emulsification, desolvation, electrospray, and coacervation. Characteriza-
tion parameters of these nano-formulations involve morphology of particle, size of
a particle, their surface charge, entrapment of drug, loading of a drug, structure of
the particle, and in vitro drug release. Different methods for the application of route
of administration for protein nanoparticles have been studied by renowned
researchers [170]. In nature, particular proteins have a self-assembling property
inside cells leading to the formation of nanoscale particles (called “proteinticles”)
with constant surface topology and structure [171]. Unlike chemically synthesized
nano-formulations (e.g., various carbon, metal and polymer nanoparticles), a set of
effective proteinticles can be easily produced through genetic modulation of the
proteinticles surface, i.e., by inserting or adding specified peptides/proteins to the
C- or -N-terminus or the internal region of the modified protein. Proteins/peptides
were presented that were proven to recognize specific antibodies in certain diseases
that were recognized on the outer surface of human ferritin based proteinticles
purposed at accurate 3D diagnosis of human infectious and autoimmune diseases.
The surface exhibited the extracellular domain of myelin oligodendrocyte glyco-
protein (MOG) with native conformation successfully differentiated between auto-
antibodies to denatured or native MOG, leading to an accurate diagnosis of multiple
sclerosis. Different antigenic peptides from the hepatitis C virus (HCV) were
displayed simultaneously on the same proteinticles surface with modification of the
composition of each peptide. Proteinticles having heterogeneous peptide surfaces
were detected with anti-HCV antibodies in patient serum with 100% accuracy. The
desired method of proteinticles engineering can be used in general to the specific
and sensitive diagnosis of several human diseases [171].
The aptamer is defined as an oligonucleotide-based nano-formulation. Unique
characteristics of aptamer exhibit specificity and high-binding affinity with target
molecules both intra- and extracellular. It functions as an agonist or antagonist in a
biological system [170]. Recently, numerous aptamers were used for the detection
of disease, with curative purposes under development for the identification of
different molecules of HCC (hepatocellular carcinoma). The aptamer has been
proved to improve the effectiveness of conventional chemotherapies and decrease
the growth of HCC cells in vitro. Aptamer was proved to elicit antitumor activity
and cell death in vivo. The overall data showed that aptamer possessed reduced
toxicity levels. Moreover, it may provide a safer base in the field of personalized
medicine [170].
Tumor Necrosis Factor-α (TNF-α) by gold protein chip was sensed using a total
internal reflection fluorescence microscopy (TIRFM) as a detection method for a
nano-based single biomarker for oral cancer diagnosis. Authors observed this
method which is an attomolar (aM) concentration level leading to a higher
sensitivity of oral cancer detection [172].
Apoferritin Ferritin is a complex of an iron-containing protein having 24 self-
assembled polypeptide subunits with external and internal diameters of 12 and
7.6 nm, respectively [173]. These protein-based cage-like networks show three
characteristic interfaces, the interior, exterior, and the interface present between
the subunits, which exhibit functionalization. When the iron core from the inner
cavity is removed, it results in a hollow protein cage-like called the Apoferritin
nanocage, which is subjected to assembling and disassembling as a result of the
change in the environment surrounding the molecule. Apoferritin nanocage can be
utilized to insert inorganic metals inside its cavity purposing at scavenging ROS
which are generated during several mechanisms in the cellular environment. This
character has been used as a template for the synthesis of an array of
nanocomposites for theragnostic applications in cancer treatment. Apoferrtin
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Micro-encapsulating materials Active compounds Micro-encapsulation techniques Applications EE % Ref.
Protein Other materials
Barley protein — Fish oil Spray drying Reducing the inflammation and
improving the hypertriglyceridemia
EE: 92.9% [174]





WPI protein — Docosahexan-oic acid Spray drying Improving the hypertriglyceridemia EE: 93.2% [176]
Zein and WPI proteins — β-carotene Spray drying Inhibiting the DNA damage and
enhancing the immune system
EE: 74.0% [177]
Casein protein Lactose Oil/milkfat compounds Spray drying Reducing the lipid oxidation problem EE: 95.2% [178]
Gelatin — Ciprofloxacin Spray drying Respiratory tract infection treatment EE: 80.0% [179]
Ethyl cellulose Curcumin Spray drying Bladder cancer treatment — [180]
GPTMS Vancomycin Emulsification Skin and joint infections treatment — [181]
WPI — Riboflavin Desolvation and Spray drying Ariboflavinosis treatment EE: 96.6% [182]
BSA protein Ch and HA Sorafenib Complexation Hepatocellular carcinoma treatment EE: 45.6% [183]
— Hemoglobin Co-precipitation Erythrocytes Shortage treatment EE: 82.0% [184]
Pea protein Polyglycerol polyricinoleate Riboflavin Emulsification Ariboflavinosis treatment EE: 84.0% [185]
EE: Encapsulation Efficiency; GPTMS: 3-glycidoxypropyltrimethoxysilane; WPI: Whey protein isolate; BSA: Bovine serum albumin; Ch: Chitosan; HA: hyaluronic acid.
Table 5.





























nanoparticles enter the targeted tumor cells via clathrin-mediated endocytosis,
receptor-mediated endocytosis, and macropinocytosis processes.
A ferritin-based multifunctional nanomaterial was prepared for MR and fluo-
rescence simultaneous imaging of lung cancer cells. Human H-chain ferritin was
engineered with green fluorescent protein aiming at stable fluorescence in the
cells. Moreover, arginylglycylaspartic acid peptide was fused on the external
surface of the ferritin cage for αvβ3 integrin receptors targeting human tumor
cells (human glioblastoma U87MG cells and A549 cells) [173]. Multifunctional
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— Celecoxib Coacervation Inflammation treatment 216.1 nm
EE: 90.7%
[196]





















EE: Encapsulation Efficiency; SPI: Soy protein isolate; WPC: Whey protein concentrate; WPI: Whey protein isolate;
Ch:Chitosan; CDF: di-fluorinated curcumin; CMCFG: carboxymethylated corn fiber gum.
Table 6.
Plant and animal proteins-based nano-encapsulated carriers for delivery of bioactive compounds.
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and GFP-rFH/Fe3O4) were prepared by synthesizing iron oxide (Fe3O4)
nanoparticles in the previously engineered ferritin cages. Imaging of these cages
with fluorescence targeted to αvβ3 integrin-positive A549 and U87MG cells showed
higher-intensity fluorescence with RGF, when compared to GFP-rHF control cells.
Furthermore, MRI with RGF showed significant enhancement of the signal to
facilitate meticulous diagnosis, when compared to GFP-rHF/Fe3O4 or without con-
trast agent. Therefore, efficient targeting and fluorescence imaging of lung cancer
cells utilizing engineered nanocages were proved to be a useful vehicle among the
different multifunctional, nanostructured, protein-based tools to be used in
fluorescent imaging.
The antioxidant enzymes present normally inside the human body, like catalase,
superoxide dismutase (SOD), and peroxidase, fail in the protection of the cells
under sudden oxidative damage/stress conditions Thus, further studies have devel-
oped artificial antioxidants capable of decreasing oxidative stress during lung can-
cer treatment [173]. Apoferritin-encapsulated protein nanoparticles have been
prepared as artificial antioxidants on account of their peroxidase, catalase, and
SOD-mimicking activity. Apoferritin-CeO2 nano-truffle has been used as an artifi-
cial redox enzyme owing to its ability to mimic SOD activity. This character can be
utilized to combat ROS-mediated lung cancer by scavenging hydrogen superoxide,
peroxide, and other small molecules triggered in sudden oxidative damage. Thus,
these systems show potential for hopeful application in lung cancer treatment [173].
Tables 5 and 6 indicate applications based on micro- and nano-encapsulation
utilizing animal/plant proteins as encapsulating materials.
4. Conclusions and future trends
This chapter describes in details the applications of polysaccharides, and pro-
teins, as natural nanocarriers for encapsulation and safe delivery of various thera-
peutic, diagnostic and theragnostic agents. The chapter provides detailed discussion
with recent examples and case studies for using polysaccharides and proteins as
biocompatible, biodegradable nanocarriers for encapsulation and delivery of small
molecules, biologics, and diagnostics.
Encapsulation will remain a valuable process in the design and development of
drug delivery systems and fabrication of diagnostic tools. Advances in naturapo-
lyceutics and encapsulation technologies will continue to drive the applicability of
natural polymers and encapsulation in drug delivery and diagnostics. More of poly-
mer blending or interactions; increasing combination of the classes of natural poly-
mers will be observed to achieve the evolving need to improve on the delivery of
existing drugs and drugs in the development pipeline. The desire to enhance selec-
tivity, specificity and sensitivity of biosensors will continue to drive the innovations
and applications of natural polymers in diagnostic space. Filling the gaps in patient
related therapies will place encapsulation as the main stay technology in solving
delivery related problems and diagnostic challenges. The quest for maximization,
cost effectiveness, reducing patient complications, and optimization of systems and
devices will lead to increased assembling of multifunctional all-in-one devices.
Theragnostics has come to stay and will precipitate combination of natural poly-
mers and encapsulation technologies to achieve the desired theragnostics that will
detect biomarkers, bioimage; and target, deliver and monitor drugs at the site of
action. As drug delivery and diagnostics advance, natural polymers will remain
materials of focus due to their biogenicity, biodegradability, biocompatibility, good
interactions with living cells, suitability for long circulation and targeting, and cell
recognition.
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